Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001722417 | SCV000589722 | likely pathogenic | not provided | 2024-07-15 | criteria provided, single submitter | clinical testing | Observed in the homozygous and compound heterozygous states in patients with arthrogryposis; however, features specific to kEDS, such as congenital hypotonia and kyphoscoliosis, were not reported (PMID: 33587123, 31428121); In silico analysis supports a deleterious effect on protein structure/function; In-frame deletion of one amino acid in a non-repeat region; This variant is associated with the following publications: (PMID: 24677762, 24773188, 27149304, 22265013, 31428121, 34682862, 33587123, 37432431) |
Labcorp Genetics |
RCV000552587 | SCV000652316 | likely benign | Ehlers-Danlos syndrome, kyphoscoliotic type, 2 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279276 | SCV002566000 | uncertain significance | Ehlers-Danlos syndrome | 2020-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350107 | SCV002652444 | likely benign | Cardiovascular phenotype | 2019-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV001722417 | SCV002817278 | uncertain significance | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | This observation is not an independent occurrence and has been identified in the same individual by RCIGM, the other laboratory participating in the GEMINI study. |
Mayo Clinic Laboratories, |
RCV001722417 | SCV004224003 | uncertain significance | not provided | 2022-02-11 | criteria provided, single submitter | clinical testing | BS1 |